Differential expression pattern of annexin A2 during nephrogenesis and kidney carcinoma

Roshni Sadashiv1, Balappa Murgappa Bannur, Praveenkumar Shetty

  • 1Department of Biochemistry, K.S. Hegde Medical Academy, Nitte University Center for Science Education and Research, Nitte University, Mangalore, Karnataka, India; shettybp@hotmail.com.

Insights

Annexin A2 (AnxA2) expression in developing kidneys mirrors its reappearance in renal cell carcinoma (RCC). This suggests AnxA2 deregulation during tumorigenesis plays a key role in kidney cancer progression.

Area of Science:

  • Oncology
  • Developmental Biology
  • Molecular Biology

Background:

  • Renal cell carcinoma (RCC) arises from embryonic kidney cells, with diverse phenotypes linked to nephron origins.
  • Annexin A2 (AnxA2), a calcium-regulated protein, is found in some renal neoplasms.
  • Understanding AnxA2's role in kidney development and cancer is crucial for comprehending RCC pathogenesis.

Purpose of the Study:

  • To investigate the ontogeny of AnxA2 expression during renal development.
  • To compare AnxA2 expression in fetal kidneys, adult kidneys, and RCCs.
  • To elucidate the role of AnxA2 in renal tumorigenesis and cancer progression.

Main Methods:

  • Immunohistochemistry was used to evaluate AnxA2 immunoexpression.
  • Tissue samples included autopsied fetal kidneys, normal adult kidneys, and renal cancer specimens.
  • Expression patterns were analyzed across different developmental stages and in neoplastic tissues.

Main Results:

  • Moderate membranous AnxA2 expression was observed in fetal ureteric buds and collecting tubules, and adult collecting ducts.
  • AnxA2 was minimally expressed in adult proximal convoluted tubules but present in fetal ones, a potential origin of RCC.
  • Strong membranous AnxA2 reappearance was noted in clear cell carcinoma, indicating gene deregulation.

Conclusions:

  • AnxA2 immunoexpression patterns during renal development and in RCC suggest its involvement in tumorigenesis.
  • Deregulation of AnxA2 during cancer development is implicated in RCC progression.
  • AnxA2's specific function and altered expression highlight its decisive role in renal carcinoma pathogenesis.